Humana (HUM) Stock Forecast & Price Target

Compare

2,458 Followers

See the Price Targets and Ratings of:

All Analysts

Top Analysts

Premium

HUM Analyst Ratings

Moderate Buy

7 Buy

7 Hold

0 Sell

Based on 14 analysts giving stock ratings to

Humana

in the past 3 months

TipRanks enables you to focus on the analyst rating consensus of all analysts or only the top performers in the past 3 months

HUM Stock 12 Month Forecast

Average Price Target

$300.57

▲(28.96%Upside)

Based on 14 Wall Street analysts offering 12 month price targets for Humana in the last 3 months. The average price target is $300.57 with a high forecast of $348.00 and a low forecast of $268.00. The average price target represents a 28.96% change from the last price of $233.07.

{"navigator":{"disabled":true},"exporting":{"enabled":false},"title":{"text":null},"chart":{"height":200,"style":{"fontFamily":"Roboto Flex","fontWeight":"400","color":"#5d5d5e"},"spacingTop":30,"spacingRight":60,"events":null},"yAxis":{"labels":{"style":{"color":"inherit"},"distance":6,"x":-6,"y":-6,"zIndex":1,"map_label_formatter":{"230":"$230","265":"$265","300":"$300","335":"$335","370":"$370"}},"plotLines":[{"color":"rgba(0,0,0,0)","value":348,"label":{"className":" overflowvisible_force","align":"right","x":60,"y":-10,"text":"<div  class=\"positionrelative hoverZ3 triangleleft-bottom flexccc bgwhite shadowhard-3 border1 borderColorwhite-8 colorwhite-8 px2 lineHeight3 fontWeightsemibold fontSize10 radiismall h_pxsmall35\"> <div class=\"w_pxsmall60 flexccc\">\n  <span style=\"color:#199ca5\">High </span>\n\n  <span style=\"color:#199ca5\">$348.00</span>\n  </div></div>","useHTML":true}},{"color":"rgba(0,0,0,0)","value":300.57,"label":{"className":" overflowvisible_force","align":"right","x":60,"y":0,"text":"<div  class=\"positionrelative hoverZ3 triangleleft flexccc bgwhite shadowhard-3 border1 borderColorwhite-8 colorwhite-8 px2 lineHeight3 fontWeightsemibold fontSize10 radiismall h_pxsmall35\"> <div class=\"w_pxsmall60 flexccc\">\n  <span style=\"color:#828080\">Average </span>\n\n  <span style=\"color:#828080\">$300.57</span>\n  </div></div>","useHTML":true}},{"color":"rgba(0,0,0,0)","value":268,"label":{"className":" overflowvisible_force","align":"right","x":60,"y":10,"text":"<div  class=\"positionrelative hoverZ3 triangleleft-top flexccc bgwhite shadowhard-3 border1 borderColorwhite-8 colorwhite-8 px2 lineHeight3 fontWeightsemibold fontSize10 radiismall h_pxsmall35\"> <div class=\"w_pxsmall60 flexccc\">\n  <span style=\"color:#912767\">Low </span>\n\n  <span style=\"color:#912767\">$268.00</span>\n  </div></div>","useHTML":true}}],"tickPositions":[230,265,300,335,370],"lineColor":"#dddddd","gridLineWidth":1,"gridLineColor":"#dddddd","lineWidth":1,"title":{"text":""}},"plotOptions":{"series":{"states":{"inactive":{"opacity":1}}},"line":{"animation":{"duration":0},"dataLabels":{"allowOverlap":true},"borderWidth":1,"marker":{"enabled":true,"fillColor":"#FFFFFF","radius":3,"lineWidth":2,"symbol":"circle","lineColor":"#828080"}}},"xAxis":{"labels":{"style":{"color":"inherit"},"rotation":0,"map_label_formatter":{"3":"Sep<br/>2024","6":"Dec<br/>2024","9":"Mar<br/>2025","12":"Jun<br/>2025","25":"Jun<br/>2026"}},"tickPositions":[3,6,9,12,25],"plotLines":[{"color":"#dddddd","width":1,"value":12},{"color":"#dddddd","width":1,"value":12}],"lineWidth":0,"gridLineWidth":1,"gridLineColor":"#dddddd","tickLength":0},"legend":{"symbolRadius":0,"symbolPadding":4,"symbolHeight":14,"borderWidth":0,"symbolWidth":14,"align":"left","verticalAlign":"bottom","enabled":false},"tooltip":{"backgroundColor":"rgba(0,0,0,0)","useHTML":true,"borderWidth":0,"borderColor":"rgba(0,0,0,0)","padding":0,"shadow":null,"headerFormat":"","footerFormat":"","pointFormat":"<div class=\"flexccc lineHeight2 bgwhite shadow2 px3 py3 radiismall fonth10_semibold\">\n                <span class=\"colorgray-3 mb4\">{point.date:%b %d ,%Y}</span>\n                <span>Analyst Consensus</span>\n                {point.info}\n          </div>\n           </div>"},"credits":{"enabled":false},"accessibility":{"description":""},"responsive":{"rules":[{"chartOptions":{"chart":{"spacing":[0,0,0,0],"margin":[30,60,40,5]},"xAxis":{"tickPositions":[3,12,25.25]},"yAxis":{"labels":{"enabled":false}},"title":{"text":null},"subtitle":{"text":null}},"condition":{"maxWidth":500}}]},"series":[{"lineWidth":2,"dashStyle":"ShortDash","name":"High","type":"line","color":"#199ca5","enableMouseTracking":false,"marker":{"enabled":false},"data":[null,null,null,null,null,null,null,null,null,null,null,null,231.39,240.35999999999999,249.32999999999998,258.3,267.27,276.24,285.21,294.18,303.15,312.12,321.09,330.06,339.03,{"y":348,"marker":{"fillColor":"#199ca5","lineColor":"#199ca5","enabled":true,"symbol":"circle"}}]},{"lineWidth":2,"dashStyle":"ShortDash","name":"Average","type":"line","color":"#828080","enableMouseTracking":false,"marker":{"enabled":false},"data":[null,null,null,null,null,null,null,null,null,null,null,null,231.39,236.71153846153845,242.03307692307692,247.35461538461539,252.67615384615382,257.9976923076923,263.3192307692308,268.64076923076925,273.96230769230766,279.2838461538461,284.6053846153846,289.92692307692306,295.2484615384615,{"y":300.57,"marker":{"fillColor":"#828080","lineColor":"#828080","enabled":true,"symbol":"circle"}}]},{"lineWidth":2,"dashStyle":"ShortDash","name":"Low","type":"line","color":"#912767","enableMouseTracking":false,"marker":{"enabled":false},"data":[null,null,null,null,null,null,null,null,null,null,null,null,231.39,234.20615384615382,237.0223076923077,239.83846153846153,242.65461538461537,245.47076923076924,248.28692307692307,251.1030769230769,253.91923076923075,256.7353846153846,259.5515384615385,262.3676923076923,265.18384615384616,{"y":268,"marker":{"fillColor":"#912767","lineColor":"#912767","enabled":true,"symbol":"circle"}}]},{"type":"line","data":[{"y":353.86,"date":1717200000000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 17,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 19, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":369.94,"date":1719792000000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 8,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 9, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":355.57,"date":1722470400000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 10,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 10, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":351.1,"date":1725148800000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 10,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 7, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":277.56,"date":1727740800000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 19,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 27, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 2</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":258.95,"date":1730419200000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 18,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 28, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 2</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":291.15,"date":1733011200000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 16,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 36, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 2</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":252.88,"date":1735689600000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 5,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 17, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":292.27,"date":1738368000000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 7,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 25, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":269.53,"date":1740787200000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 9,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 18, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":264.74,"date":1743465600000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 13,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 25, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":256.04,"date":1746057600000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 14,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 17, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":231.39,"date":1748736000000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 13,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 18, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"fillColor":"black","lineColor":"black","enabled":true,"symbol":"circle"}},null,null,null,null,null,null,null,null,null,null,null,null],"color":"#0666a7"}]}

Highest Price Target$348.00

Average Price Target$300.57

Lowest Price Target$268.00

The highest, average, and lowest price target of all analysts. Click on ‘Top Analysts’ to focus on the best performers.

Detailed List of Analyst Forecasts

TipRanks AITipRanks

Not Ranked

TipRanks

$259

Buy

11.13%

Upside

Upgraded

05/31/25

Humana's strong financial performance and recent corporate events underpin a favorable outlook. While valuation remains fair and the company shows operational strength, technical analysis suggests caution due to lack of upward momentum. External uncertainties from regulatory challenges and litigation also temper the overall score.

Lance WilkesBernstein

Bernstein

$313

Buy

34.29%

Upside

Assigned

06/06/25

Bernstein Sticks to Its Buy Rating for Humana (HUM)

Stephen BaxterWells Fargo

Wells Fargo

$380→$348

Buy

49.31%

Upside

Reiterated

06/05/25

Humana (HUM) Gets a Buy from Wells Fargo

Sarah JamesCantor Fitzgerald

Cantor Fitzgerald

$290

Hold

24.43%

Upside

Reiterated

06/04/25

Humana (HUM) Gets a Hold from Cantor Fitzgerald

Andrew Mok CFABarclays

Barclays

$322→$273

Hold

17.13%

Upside

Reiterated

06/03/25

Humana price target lowered to $273 from $322 at BarclaysHumana price target lowered to $273 from $322 at Barclays

David S MacdonaldTruist Financial

Truist Financial

$325→$305

Hold

30.86%

Upside

Reiterated

05/12/25

Humana price target lowered to $305 from $325 at TruistHumana price target lowered to $305 from $325 at Truist

Michael WiederhornOppenheimer

Oppenheimer

$300→$310

Buy

33.01%

Upside

Reiterated

05/01/25

Humana price target raised to $310 from $300 at OppenheimerHumana price target raised to $310 from $300 at Oppenheimer

John RansomRaymond James

Raymond James

$315

Buy

35.15%

Upside

Upgraded

05/01/25

Positive Report for Humana (HUM) from Raymond James

Whit MayoLeerink Partners

Leerink Partners

$282→$271

Hold

16.27%

Upside

Reiterated

05/01/25

Leerink Partners Remains a Hold on Humana (HUM)

Ben HendrixRBC Capital

RBC Capital

$283

Buy

21.42%

Upside

Reiterated

05/01/25

Analysts Offer Insights on Healthcare Companies: Moderna (NASDAQ: MRNA), Humana (NYSE: HUM) and Exact Sciences (NASDAQ: EXAS)

Ryan LangstonTD Cowen

TD Cowen

$268

Hold

14.99%

Upside

Reiterated

05/01/25

Humana's Hold Rating: Balancing Positive EPS Guidance with Legal and Margin Uncertainties

Erin WrightMorgan Stanley

Morgan Stanley

$290

Hold

24.43%

Upside

Reiterated

04/28/25

Cautious Outlook on Humana Amid Market Position and Litigation Uncertainties

Michael HaRobert W. Baird

Robert W. Baird

$270→$300

Hold

28.72%

Upside

Reiterated

04/15/25

Humana price target raised to $300 from $270 at BairdHumana price target raised to $300 from $270 at Baird

Ann HynesMizuho Securities

Mizuho Securities

$305→$316

Buy

35.58%

Upside

Reiterated

04/09/25

Humana price target raised to $316 from $305 at MizuhoHumana price target raised to $316 from $305 at Mizuho

Jason CassorlaGuggenheim

Guggenheim

$326

Buy

39.87%

Upside

Initiated

04/09/25

Guggenheim starts Humana (HUM) at Buy

Ranks

Any

Analyst Rating

Any

Upside/ Downside

Any

Action

Any

TipRanks AITipRanks

Not Ranked

TipRanks

$259

Buy

11.13%

Upside

Upgraded

05/31/25

Lance WilkesBernstein

Bernstein

$313

Buy

34.29%

Upside

Assigned

06/06/25

Bernstein Sticks to Its Buy Rating for Humana (HUM)

Stephen BaxterWells Fargo

Wells Fargo

$380→$348

Buy

49.31%

Upside

Reiterated

06/05/25

Humana (HUM) Gets a Buy from Wells Fargo

Sarah JamesCantor Fitzgerald

Cantor Fitzgerald

$290

Hold

24.43%

Upside

Reiterated

06/04/25

Humana (HUM) Gets a Hold from Cantor Fitzgerald

Andrew Mok CFABarclays

Barclays

$322→$273

Hold

17.13%

Upside

Reiterated

06/03/25

Humana price target lowered to $273 from $322 at BarclaysHumana price target lowered to $273 from $322 at Barclays

David S MacdonaldTruist Financial

Truist Financial

$325→$305

Hold

30.86%

Upside

Reiterated

05/12/25

Humana price target lowered to $305 from $325 at TruistHumana price target lowered to $305 from $325 at Truist

Michael WiederhornOppenheimer

Oppenheimer

$300→$310

Buy

33.01%

Upside

Reiterated

05/01/25

Humana price target raised to $310 from $300 at OppenheimerHumana price target raised to $310 from $300 at Oppenheimer

John RansomRaymond James

Raymond James

$315

Buy

35.15%

Upside

Upgraded

05/01/25

Positive Report for Humana (HUM) from Raymond James

Whit MayoLeerink Partners

Leerink Partners

$282→$271

Hold

16.27%

Upside

Reiterated

05/01/25

Leerink Partners Remains a Hold on Humana (HUM)

Ben HendrixRBC Capital

RBC Capital

$283

Buy

21.42%

Upside

Reiterated

05/01/25

Analysts Offer Insights on Healthcare Companies: Moderna (NASDAQ: MRNA), Humana (NYSE: HUM) and Exact Sciences (NASDAQ: EXAS)

Ryan LangstonTD Cowen

TD Cowen

$268

Hold

14.99%

Upside

Reiterated

05/01/25

Humana's Hold Rating: Balancing Positive EPS Guidance with Legal and Margin Uncertainties

Erin WrightMorgan Stanley

Morgan Stanley

$290

Hold

24.43%

Upside

Reiterated

04/28/25

Cautious Outlook on Humana Amid Market Position and Litigation Uncertainties

Michael HaRobert W. Baird

Robert W. Baird

$270→$300

Hold

28.72%

Upside

Reiterated

04/15/25

Humana price target raised to $300 from $270 at BairdHumana price target raised to $300 from $270 at Baird

Ann HynesMizuho Securities

Mizuho Securities

$305→$316

Buy

35.58%

Upside

Reiterated

04/09/25

Humana price target raised to $316 from $305 at MizuhoHumana price target raised to $316 from $305 at Mizuho

Jason CassorlaGuggenheim

Guggenheim

$326

Buy

39.87%

Upside

Initiated

04/09/25

Guggenheim starts Humana (HUM) at Buy

Stocks with the Highest Top Analyst Consensus in the Healthcare Sector

xxx

Find stocks in the Healthcare sector that are highly recommended by Top Performing Analysts.

Best Analysts Covering Humana

1 Month

xxx

Success Rate

23/37 ratings generated profit

Average Return

+0.90%

reiterated a xxx

rating last month

Copying xxxxxxxxxxxxxxxxxx

trades and holding each position for 1 Month would result in 62.16% of your transactions generating a profit, with an average return of +0.90% per trade.

3 Months

xxx

Success Rate

25/37 ratings generated profit

Average Return

+1.96%

reiterated a xxx

rating last month

Copying xxxxxxxxxxxxxxxxxx

trades and holding each position for 3 Months would result in 67.57% of your transactions generating a profit, with an average return of +1.96% per trade.

1 Year

Michael WiederhornOppenheimer

Success Rate

21/37 ratings generated profit

Average Return

+3.30%

reiterated a buy rating last month

Copying Michael Wiederhorn's trades and holding each position for 1 Year would result in 56.76% of your transactions generating a profit, with an average return of +3.30% per trade.

2 Years

xxx

Success Rate

26/37 ratings generated profit

Average Return

+9.05%

reiterated a xxx

rating last month

Copying xxxxxxxxxxxxxxxxxx

trades and holding each position for 2 Years would result in 70.27% of your transactions generating a profit, with an average return of +9.05% per trade.

The Best Analyst Covering tool allows you to follow the analysts who have the best success rates and average returns on a specific stock. Only analysts that gave a Buy or Sell rating on the stock in the past 12 months are eligible for inclusion in this tool. Follow the analysts of your choice to receive real-time updates when they publish a new rating.

HUM Analyst Recommendation Trends

Rating

Feb 25

Mar 25

Apr 25

May 25

Jun 25

Strong Buy

Buy

Hold

Sell

Strong Sell

total

In the current month, HUM has received 13 Buy Ratings, 18 Hold Ratings, and 0 Sell Ratings. HUM average Analyst price target in the past 3 months is 300.57.

Each month's total comprises the sum of three months' worth of ratings.

HUM Financial Forecast

HUM Earnings Forecast

Next quarter’s earnings estimate for HUM is $5.90 with a range of $5.08 to $8.30. The previous quarter’s EPS was $11.58. HUM beat its EPS estimate 100.00% of the time in the past 12 months, while its overall industry beat the EPS estimate 48.39% of the time in the same period. In the last calendar year HUM has Outperformed its overall industry.

HUM Sales Forecast

Next quarter’s sales forecast for HUM is $31.85B with a range of $31.41B to $32.35B. The previous quarter’s sales results were $32.11B. HUM beat its sales estimates 75.00% of the time in past 12 months, while its overall industry beat sales estimates 46.89% of the time in the same period. In the last calendar year HUM has Outperformed its overall industry.

HUM Stock Forecast FAQ

What is HUM’s average 12-month price target, according to analysts?

Based on analyst ratings, Humana’s 12-month average price target is 300.57.

What is HUM’s upside potential, based on the analysts’ average price target?

Humana has 28.96% upside potential, based on the analysts’ average price target.

Can I see which stocks the top-ranking analysts are rating?

Yes, go to the Analysts’ Top Stocks tool to see stocks with a Strong Buy or Strong Sell analyst rating consensus, according to the top performers.

How can I follow the stock ratings of top Wall Street analysts?

Head over to our Expert Center to see a list of the top 100 Wall Street analysts and follow the analysts of your choice. Visit their profiles for more details about their stock ratings and see how they perform on a stock-by-stock basis.

Is HUM a Buy, Sell or Hold?

Humana has a consensus rating of Moderate Buy which is based on 7 buy ratings, 7 hold ratings and 0 sell ratings.

What is Humana’s price target?

The average price target for Humana is 300.57. This is based on 14 Wall Streets Analysts 12-month price targets, issued in the past 3 months.
The highest analyst price target is $348.00 ,the lowest forecast is $268.00. The average price target represents 28.96% Increase from the current price of $233.07.

What do analysts say about Humana?

Humana’s analyst rating consensus is a Moderate Buy. This is based on the ratings of 14 Wall Streets Analysts.

How can I buy shares of HUM?

Open a brokerage account, see exclusive account opening deals on our Best Online Brokers page.

Become an Expert with TipRanks Premium

What am I Missing?

Make informed decisions based on Top Analysts' activity

Know what industry insiders are buying

Get actionable alerts from top Wall Street Analysts

Find out before anyone else which stock is going to shoot up

Get powerful stock screeners & detailed portfolio analysis

Subscribe Now See Plans & Pricing

Humana (HUM) Stock Forecast & Price Target

HUM Analyst Ratings

HUM Stock 12 Month Forecast

Average Price Target

Detailed List of Analyst Forecasts​

Best Analysts Covering Humana

HUM Analyst Recommendation Trends

HUM Financial Forecast

HUM Earnings Forecast

HUM Sales Forecast

HUM Stock Forecast FAQ

Become an Expert with TipRanks Premium

Detailed List of Analyst Forecasts